Extended-criteria donors in liver transplantation Part II: reviewing the impact of extended-criteria donors on the complications and outcomes of liver transplantation. (Q30251928)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Extended-criteria donors in liver transplantation Part II: reviewing the impact of extended-criteria donors on the complications and outcomes of liver transplantation.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26831547%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

Europe PubMed Central

Extended-criteria donors in liver transplantation Part II: reviewing the impact of extended-criteria donors on the complications and outcomes of liver transplantation (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26831547%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

liver transplantation

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26831547%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Zhassulan Baimakhanov

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26831547%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Zhassulan Baimakhanov

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26831547%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26831547%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Balázs Nemes

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26831547%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

György Gámán

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26831547%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Wojciech G Polak

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26831547%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Fanni Gelley

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26831547%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Shinichiro Ono

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26831547%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Laszlo Piros

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26831547%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

2 March 2016

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26831547%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Expert Review of Gastroenterology & Hepatology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26831547%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26831547%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26831547%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

841-859

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26831547%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Prediction of graft dysfunction based on extended criteria donors in the model for end-stage liver disease score era.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Liver recipient survival rate before and after model for end-stage liver disease implementation and use of donor risk index

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Combination of extended donor criteria and changes in the Model for End-Stage Liver Disease score predict patient survival and primary dysfunction in liver transplantation: a retrospective analysis.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Impact of cumulative risk factors for expanded criteria donors on early survival after liver transplantation

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Hepatic steatosis is not always a contraindication for cadaveric liver transplantation

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Utilization of extended donor criteria in liver transplantation: a comprehensive review of the literature

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Expanding postmortem donor pool using steatotic liver grafts: a new look.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Short- and long-term outcomes after steatotic liver transplantation

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Outcome of liver transplantation based on donor graft quality and recipient status.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Comparison of outcomes in ideal donor and extended criteria donor in deceased donor liver transplant: a prospective study.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Donation after cardiac death liver transplant recipients have an increased frequency of acute kidney injury.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Biliary complications after liver transplantation

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Marginal grafts increase early mortality in liver transplantation

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Donation after cardio-circulatory death liver transplantation

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Outcomes with split liver transplantation in 106 recipients: the University of California, San Francisco, experience from 1993 to 2010.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Comparison of liver transplantation outcomes from adult split liver and circulatory death donors.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

A comprehensive risk assessment of mortality following donation after cardiac death liver transplant - an analysis of the national registry

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Liver transplantation with grafts from controlled donors after cardiac death: a 20-year follow-up at a single center.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Biliary complications after orthotopic liver transplantation from donors after cardiac death: broad spectrum of disease

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Biliary complications after liver transplantation using grafts from donors after cardiac death: results from a matched control study in a single large volume center

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

T-tube or no T-tube in cadaveric orthotopic liver transplantation: the eternal dilemma: results of a prospective and randomized clinical trial

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Steatosis of the hepatic graft as a risk factor for post-transplant biliary complications.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Liver transplantation using Donation after Cardiac Death donors

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Donor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Increased risk of severe recurrence of hepatitis C virus in liver transplant recipients of donation after cardiac death allografts

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Liver transplantation for hepatitis C from donation after cardiac death donors: an analysis of OPTN/UNOS data

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Liver allografts from hepatitis C positive donors can offer good outcomes in hepatitis C positive recipients: a US National Transplant Registry analysis

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Long-term follow-up and outcome of liver transplantation from anti-hepatitis C virus-positive donors: a European multicentric case-control study.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Survival after liver transplantation using hepatitis C virus-positive donor allografts: case-controlled analysis of the UNOS database

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Utilization of hepatitis C antibody-positive livers: genotype dominance is virally determined

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Survival after orthotopic liver transplantation: the impact of antibody against hepatitis B core antigen in the donor

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Utilization of hepatitis B core antibody-positive donor liver grafts

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Identification of new donor variables associated with graft survival in a single-center liver transplant cohort.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Liver transplantation using elderly donors: a risk factor analysis

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Use of octogenarian donors for liver transplantation: a survival analysis.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Safely expanding the donor pool: brain dead donors with history of temporary cardiac arrest.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Contribution of marginal donors to liver transplantation for hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Impact of the donor liver with steatosis in patients with hepatitis C virus: not so FAst

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

How can we utilize livers from advanced aged donors for liver transplantation for hepatitis C?

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Advances in machine perfusion graft viability assessment in kidney, liver, pancreas, lung, and heart transplant

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

The hepatitis C revolution part 1: antiviral treatment options

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

A complete treatment of adult living donor liver transplantation: a review of surgical technique and current challenges to expand indication of patients

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Current developments in pediatric liver transplantation

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

The utility of extended criteria donor organs in severely ill liver transplant recipients

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Optimal utilization of extended hepatic grafts

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Liver transplantation with donation after cardiac death donors: a comprehensive update

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Survival following liver transplantation from non-heart-beating donors

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Long-term outcomes of donation after cardiac death liver allografts from a single center

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Characteristics associated with liver graft failure: the concept of a donor risk index.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Feasibility of split liver transplantation for 2 adults in the model of end-stage liver disease era.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Deceased-donor split-liver transplantation in adult recipients: is the learning curve over?

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Risk of extended criteria donors in hepatitis C virus-positive recipients

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Liver transplantation using young pediatric donor grafts in adults with hepatitis C infection

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Living donor liver transplantation and hepatitis C.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Interferon-Free Sofosbuvir-Based Anti-HCV Therapy After Liver Transplantation

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Donor factors predicting recipient survival after liver retransplantation: the retransplant donor risk index

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Preserving the morphology and evaluating the quality of liver grafts by hypothermic machine perfusion: a proof-of-concept study using discarded human livers

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Split liver transplantation: past, present and future.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Is there still a need for living-related liver transplantation in children?

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Improved results for adult split liver transplantation with extended right lobe grafts: could we enhance its application?

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: Recognizing who can benefit

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Right lobe split liver transplantation versus whole liver transplantation in adult recipients: A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

A prospective policy development to increase split-liver transplantation for 2 adult recipients: results of a 12-year multicenter collaborative study.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Temperature controlled machine perfusion system for liver

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

HOPE for human liver grafts obtained from donors after cardiac death.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Preservation of steatotic livers: a comparison between cold storage and machine perfusion preservation

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Ischemic preconditioning (IP) of the liver as a safe and protective technique against ischemia/reperfusion injury (IRI).

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

The influence of storage temperature during machine perfusion on preservation quality of marginal donor livers.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

rHuEPo reduces ischemia-reperfusion injury and improves survival after transplantation of fatty livers in rats.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution in extended criteria liver donors

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Is extracorporeal hypothermic machine perfusion of the liver better than the 'good old icebox'?

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Machine perfusion for 'marginal' liver grafts

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Hypothermic Oxygenated Perfusion (HOPE) downregulates the immune response in a rat model of liver transplantation.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Artificial circulation of the liver: machine perfusion as a preservation method in liver transplantation.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

One hour hypothermic oxygenated perfusion (HOPE) protects nonviable liver allografts donated after cardiac death

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Use of a new modified HTK solution for machine preservation of marginal liver grafts.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Ex-vivo normothermic liver perfusion: an update

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Hypothermic machine preservation in human liver transplantation: the first clinical series.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Molecular expression of acute phase mediators is attenuated by machine preservation in human liver transplantation: preliminary analysis of effluent, serum, and liver biopsies.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Assist devices: machine preservation of extended criteria donors

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

The role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosis

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Human hepatic stellate cells are not permissive for hepatitis C virus entry and replication

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Ductular reactions in human liver: diversity at the interface

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Liver transplantation using organ donation after cardiac death: a clinical predictive index for graft failure-free survival

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Impact of very advanced donor age on hepatic artery thrombosis after liver transplantation

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Effects of Graft Quality on Non-Urgent Liver Retransplantation Survival: Should We Avoid High-Risk Donors?

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

A preliminary European Liver and Intestine Transplant Association-European Liver Transplant Registry study on informed recipient consent and extended criteria liver donation

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1149062

21 January 2018

Identifiers

10.1586/17474124.2016.1149062

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26831547%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26831547%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30251928&oldid=1550831791"